MedFIT is your opportunity to connect with international key innovators in the MedTech, diagnostic and digital health sectors.

As a leading European partnering event, MedFIT provides the ideal environment to help industry players to source early-stage assets, to facilitate the emergence of collaborative projects between big players, public research institutions, start-ups and SMEs, to increase licensing opportunities, to obtain funding and to facilitate market access.

Key Figures

 50
High-level speakers

 3,000 
Generated meetings

1,100 meetings realised (in 2018) 

 2
Hosted Events

(in 2018)

 1,000,000
Impressions on #MedFIT2018

(during MedFIT 2018)

🎁 CHRISTMAS OFFER 🎁 Register before December 20th and benefit from an exclusive 25% discount on the regular full pass
13 Dec
In-depth Interview with Mirren Mandalia, Johnson & Johnson Innovation Mirren Mandalia: At Johnson & Johnson Innovation, we’re passionate about changing the trajectory of human health for the better...
17 Sep
We are very honoured to count NAMSA among the Sponsors of MedFIT 2019! Many thanks to NAMSA for joining MedFIT 2019 as a Bronze Sponsor !
11 Dec
MedFIT 2019’s taking shape, discover the brochure! It is also the start of a new (school) year for MedFIT!
06 Sep
Pitch at MedFIT 2019 Are you looking for business, research or financial partners? Do you want to enhance your visibility and be recognised as an innovative key player?
27 Nov
[Waiting for #MedFIT2019] Be at the forefront of the medtech news thanks to Medical Plastics News! Interested by news about the design, manufacture and supply of medical plastics devices?
20 Jul

The Lille Region is the 3rd ranked life sciences cluster in France. The main areas of expertise in the Hauts-de-France region are metabolic diseases, ageing diseases, nutrition and blood related products. The pharma-biotech sector in Northern France enjoys the presence of both big companies (AstraZeneca, Bayer, GSK…), a dense network of innovative startups (AlzProtect, ImaBiotech, Innobiochips…) and dynamic mid-size biopharmaceutical companies (Diagast, Genfit, Genoscreen, LFB…).